Wilms tumor (WT), also known as nephroblastoma, is an extremely rare tumor with few reports in the literature. Recent reviews mention a number of about 300 cases reported 1 . Although there is no difference of cause or histology for this tumor between adults or children, the symptomatology differs when these two groups are compared. WT is an embryogenic tumor, originated from nephrogenic blastemal cells, which replicates the histology of the kidneys and usually exhibits various patterns of differentiation.
Treatment is based on surgical resection of the mass, followed by the patient's risk classification and therefore definition for the use or not of adjuvant chemotherapy and, in some cases, radiation. However, protocols are lacking of standardization for unresectable diseases or inoperable relapses 2 .
Cancer control rates of WT are worse in adults when compared to children. The reason for this disparity are factors such as diagnosis in advanced stages, lack of the knowledge of the pathology by oncologists and pathologists, absence of standardized treatment protocols and delay of risk stratification to define adjuvant treatment
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CASE REPORT
Patient is 26-year-old male who initially presented with macroscopic hematuria associated with left flank pain. Also, he had a feeling of abdominal mass on the left flank. He referred no weight loss. On physical examination, vital signs were normal and the general status of the patient was good, classified at the first clinical evaluation as Karnofsky of 80%. During abdominal examination, patient felt pain and showed a 12 cm palpable hard mass in the upper left quadrant. He referred a family history of a daughter operated when she was 2 years old by adrenal tumor although there was no pathology report available. Patient was formerly a smoker with smoking history of 8 years, 1 pack of cigarettes per day and he quit smoking 1 year ago. Laboratory exams showed blood cells count and renal function were within normal ranges. An abdominal contrasted CT-scan showed an 18 cm well delimited left renal mass, no signs of extrarenal involvement (figure 1 and 2). Thus, patient underwent an open left radical nephrectomy with para-aortic lymphadenectomy through a subcostal incision. No gross lymph nodes were found, and no infiltration to adjacent organs. Histopathology diagnosed a malignant kidney tumor, undifferentiated small cell (figures 3 and 4), measuring 16 cm. Twelve lymph nodes were dissected and all these were free of malignant cells. The immunohistochemistry study was positive for vimentin and WT-1 with Ki67 30%, suggesting morphologic features of WT (figures 5 and 6). Patient had an uneventful outcome after surgery and was discharged on post-operative day 3 presenting normal renal function. Patient was then referred to adjuvant chemotherapy with dactinomycin and vincristine. After 12 months follow-up, patient is still free of disease. 
DISCUSSION
WT is an extremely rare neoplasia in adults. While in children it represents about 95% of renal neoplasms, 4 in adults it corresponds to less than 1% of all kidney cancers 5 .
The clinical presentation consists mainly of abdominal or flank pain, weight loss, anorexia and a deterioration in status performance 6 ; on the other hand, pediatric patients frequently present with an asymptomatic abdominal mass 7 . In the majority of cases, the clinical scenario and imaging tests cannot distinguish between WT and other renal neoplasms, and mainly tumor final diagnosis is only achieved by pathological analysis 6 . Usually the diagnosis is only made after nephrectomy on suspicion of clear cell carcinoma, the most common kidney tumor in adults. At diagnosis, adults have more advanced disease 6 , 50% of them already presenting stages III and IV 8 as well as more metastases at diagnosis, especially to the lungs 6, 9 , when compared to children. Kilton et al Macroscopically, WT usually presents as a spherical mass on the periphery or central area of the kidney, with a soft consistency and usually gray or brown in color. There may be areas of hemorrhage or necrosis 11 . Classic WT has a triphasic appearance, with varying proportions of three cell types (blastemal, stromal and epithelial). The neoplasm may show extreme histological diversity, which may lead to diagnostic difficulties and final characterization may be challenging. The main microscopic pathology finding is the presence of small round cell tumors with high nucleus/cytoplasm ratio and may be present rosettes. Pathology may show nephrogenic rests in approximately 25-40% cases 12 . Immunohistochemistry may be essential in the differentiation of WT, which is WT1 positive and rarely positive for CD99, this one a very important piece of information to differentiate WT from PNET neoplasms. The blastemal component (cell compact areas) of WT consisted of vimentin-positive cells 13 .
Genetically, many genes have been implicated in the development of WT, among them: WT1 (11p13), WT2 (11p15) and abnormalities in 16p, 1p and 17p. Mutations of the p53 tumor suppressor gene may also be present in WT anaplastic forms 14 .
The pathological assessment provides essential information to determine prognosis. Factors that need to be evaluated are capsular invasion, renal vein invasion, resection margins, lymph node status and renal sinus involvement including venous and lymphatic invasion in the sinus 11 .
The recommended treatment for WT in adults follows protocols established for pediatric patients by the National Wilms Tumor Study Group (NWTS) and Societe Internationale D'oncologie pédiatrique (SIOP). The treatment consists of radical nephrectomy followed by systemic chemotherapy. Radiotherapy should be performed in stages III and IV, on renal bed and metastases sites when needed 6, 15 . The toxicity related to chemotherapy appears to be greater in adults, mainly associated with vincristine and dactinomycin 6, 9 . To try to avoid toxicity, it is suggested that, in adults, the dose adjustment should be made in accordance with the body surface area and not to the body weight, like it is done in children patients 9 .
Currently, 5-year survival rates in adults with WT is approximately 90% 6 . This large improvement is due to the adoption of systematized multimodal therapy proposed by protocols and advances in surgical techniques. Also, the effectiveness of chemotherapeutic agents and radiotherapy allowed the results to become as satisfactory as those observed in children, when exposed to the same treatment regimen, with similar histology and tumor stage 6, 16 .
CONCLUSION
WT in adults is uncommon. Due to the rarity of the disease in the adult population, the diagnosis is challenging, mainly requiring immunohistochemistry for the differentiation from other renal neoplasms. There is no specific treatment protocol for this pathology in adults, and management follows the same steps as for the pediatric group.
